Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

rugby laboratories - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz, bismuth cation - unii:zs9cd1i8ye) - bismuth subsalicylate 262 mg in 15 ml - upset stomach reliever and antidiarrheal - relieves upset stomach due to overindulgence in food and drink - controls diarrhea

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

geri-care pharmaceuticals, corp - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz, bismuth cation - unii:zs9cd1i8ye) - bismuth subsalicylate 262 mg in 15 ml - upset stomach reliever and antidiarrheal relieves - travelers’ diarrhea - diarrhea - upset stomach due to overindulgence in food and drink, including: - heartburn - indigestion - nausea

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

kareway product, inc. - bismuth subsalicylate (unii: 62tey51rr1) (bismuth subsalicylate - unii:62tey51rr1) - bismuth subsalicylate 262 mg in 15 ml - upset stomach reliever and antidiarrheal relieves - heartburn - indigestion - upset stomach - nausea - diarrhea

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

kc pharmaceuticals, inc. - bismuth subsalicylate, 262 mg - bismuth subsalicylate - upset stomach reliever and antidiarrheal - upset stomach - indigestion - nausea - heartburn - diarrhea

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

p & l development, llc - bismuth subsalicylate 262 mg - • an ulcer • a bleeding problem • bloody or black stool • fever • mucus in stool • anticoagulation (thinning blood) • diabetes • gout • arthritis • symptoms get worse • ringing in the ears or loss of hearing occurs • diarrhea lasts more than 2 days relieves • upset stomach • heartburn • indigestion • diarrhea • nausea bismuth subsalicylate....................upset stomach reliever/antidiarrheal

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

rite aid corporation - bismuth subsalicylate 262 mg - • an ulcer • a bleeding problem • bloody or black stool • fever • mucus in stool • anticoagulation (thinning blood) • diabetes • gout • arthritis • symptoms get worse • ringing in the ears or loss of hearing occurs • diarrhea lasts more than 2 days relieves • upset stomach • heartburn • indigestion • diarrhea • nausea bismuth subsalicylate....................upset stomach reliever/antidiarrheal

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

lannett company, inc. - diphenoxylate (unii: 73312p173g) (diphenoxylate - unii:73312p173g), atropine (unii: 7c0697dr9i) (atropine - unii:7c0697dr9i) - diphenoxylate 2.5 mg - diphenoxylate hcl and atropine sulfate tablets are indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older. diphenoxylate hcl and atropine sulfate tablets are contraindicated in: - pediatric patients less than 6 years of age due to the risks of respiratory and central nervous system (cns) depression (see warnings ). pediatric patients less than 6 years of age due to the risks of respiratory and central nervous system (cns) depression (see warnings ). - patients with diarrhea associated with pseudomembranous enterocolitis (clostridium difficile ) or other enterotoxin-producing bacteria due to the risk of gastrointestinal (gi) complications, including sepsis (see warnings ). patients with diarrhea associated with pseudomembranous enterocolitis (clostridium difficile ) or other enterotoxin-producing bacteria due to the risk of gastrointestinal (gi) complications, including sepsis (see warnings ). - patients with known hypersensitivity to diphenoxylate or atropine. patients with known hypersensitivity to diphenoxylate or atropine. - patients with obstructive jaundice. patients with obstructive jaundice. controlled substance : diphenoxylate hcl and atropine sulfate tablets are classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. drug abuse and dependence : in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate hydrochloride in commonly available aqueous media precludes intravenous self-administration. a dose of 100 to 300 mg/day, which is equivalent to 40 to 120 tablets, administered to humans for 40 to 70 days, produced opiate withdrawal symptoms. since addiction to diphenoxylate hydrochloride is possible at high doses, the recommended dosage should not be exceeded.

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

menper distributors, inc. - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 262 mg in 15 ml - purpose upset stomach reliever and antidiarrheal uses relieves: - heartburn - indigestion - upset stomach - nausea - diarrhea allergy alert: contains salicylate. do not take if you are: allergic to salicilates (including aspirin) taking other salicylate products do not use if you have: - an ulcer - a bleeding problem - bloody or black stool stop use and ask a doctor if: - symptoms get worse - ringing in the ears or loss of hearing occurs - diarrhea lasts more than 2 days

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride 2.5 mg - diphenoxylate hydrochloride is effective as adjunctive therapy in the management of diarrhea. diphenoxylate hydrochloride is contraindicated in patients with: - known hypersensitivity to diphenoxylate or atropine. - obstructive jaundice. - diarrhea associated with pseudomembranous enterocolitis or enterotoxin-producing bacteria. diphenoxylate hydrochloride is classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate hydrochloride in commonly available aqueous media precludes intravenous self-

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

atlantic biologicals corps - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride 2.5 mg - diphenoxylate hydrochloride is effective as adjunctive therapy in the management of diarrhea. diphenoxylate hydrochloride is contraindicated in patients with: - known hypersensitivity to diphenoxylate or atropine. - obstructive jaundice. - diarrhea associated with pseudomembranous enterocolitis or enterotoxin-producing bacteria. diphenoxylate hydrochloride is classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate hydrochloride in commonly available aqueous media precludes intravenous self-